IRIS
SORRENTINO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.463
EU - Europa 1.407
AS - Asia 904
SA - Sud America 78
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
OC - Oceania 1
Totale 3.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.459
SG - Singapore 333
CN - Cina 294
IT - Italia 258
IE - Irlanda 232
UA - Ucraina 232
SE - Svezia 199
TR - Turchia 160
GB - Regno Unito 159
FR - Francia 120
DE - Germania 86
BR - Brasile 65
IN - India 57
FI - Finlandia 51
RU - Federazione Russa 48
VN - Vietnam 20
AR - Argentina 8
HK - Hong Kong 8
PK - Pakistan 8
AT - Austria 7
NL - Olanda 5
EU - Europa 4
CA - Canada 3
CL - Cile 3
EG - Egitto 3
IL - Israele 3
IQ - Iraq 3
CZ - Repubblica Ceca 2
JP - Giappone 2
KR - Corea 2
KZ - Kazakistan 2
PL - Polonia 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BY - Bielorussia 1
EC - Ecuador 1
GR - Grecia 1
JM - Giamaica 1
LB - Libano 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.860
Salva come PNG Salva come JPEG
Città #
Chandler 274
Jacksonville 254
Dublin 232
Singapore 204
Dearborn 141
Southend 133
Princeton 107
Nanjing 79
Izmir 73
The Dalles 68
Beijing 51
Wilmington 50
Pescara 47
Cambridge 42
Santa Clara 40
Altamura 32
Nanchang 31
Boardman 26
Romola 26
Shenyang 22
Ann Arbor 21
Dong Ket 20
Chieti 17
Los Angeles 15
Grevenbroich 14
Kunming 14
Ashburn 13
Chennai 11
Falls Church 11
Woodbridge 11
Camerino 10
Düsseldorf 10
Hebei 10
Jiaxing 9
Norwalk 8
Hong Kong 7
Jinan 7
Milan 7
Nuremberg 7
Changsha 6
Hangzhou 6
Helsinki 6
Lappeenranta 5
Porto San Giorgio 5
Shanghai 5
São Paulo 5
Tandil 5
Tianjin 5
Changchun 4
Hefei 4
Islamabad 4
New York 4
Ningbo 4
Orange 4
Padova 4
Terni 4
Torino 4
Washington 4
Baghdad 3
Guangzhou 3
Lanciano 3
Leawood 3
London 3
Moscow 3
Seattle 3
Tappahannock 3
Baotou 2
Coimbatore 2
Collecorvino 2
Francavilla Al Mare 2
Frankfurt am Main 2
Irsina 2
Juiz de Fora 2
Martinsicuro 2
Montesilvano 2
Montesilvano Marina 2
Perugia 2
Pune 2
Rio de Janeiro 2
San Giovanni Teatino 2
Silver Spring 2
São Gonçalo 2
Taizhou 2
Tashkent 2
Toronto 2
Vienna 2
Xian 2
Zhengzhou 2
Almaty 1
Ameno 1
Americana 1
Amsterdam 1
Andover 1
Anicuns 1
Aracaju 1
Araraquara 1
Araras 1
Araxá 1
Astana 1
Athens 1
Totale 2.322
Salva come PNG Salva come JPEG
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 114
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 110
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 102
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 97
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 95
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 94
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 93
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 91
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 91
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 86
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 85
Interleukin-30 Promotes Breast Cancer Growth and Progression 85
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 84
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 84
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 84
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 80
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 79
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 79
The role of B lymphocytes and NK cells in cardiac allograft rejection. 79
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 79
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 78
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 77
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 77
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 76
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 76
The Quilty Effect: an actor in search of a part 75
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 74
The antitumor potential of Interleukin-27 in prostate cancer 74
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 74
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 72
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 71
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 67
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 67
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 66
Mouse tumorigenesis models as an aid to understanding human cancer. 65
Clinical impact of the lung tissue transcriptome in a teenager with multifocal invasive mucinous adenocarcinoma-a case report 64
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 63
The Lack of IL-12Rbeta2 signaling in lung adenocarcinomas is a novel mechanism of tumor escape from immune surveillance 63
The IL-12Rb2 gene protects from autoimmunity and functions as tumor suppressor in B cell malignancies. 63
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival 63
The prostate-associated lymphoid tissue (PALT) is linked to the expression of chemokines CXCL13 and CCL21. 61
Endogenous IL-12 dampens tumorigenicity of B16 melanoma cells in IL-12Rbeta2 deficient mice through direct mechanisms. 59
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 59
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival 55
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 55
Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory Diseases 50
Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling 49
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome 49
Neo-adjuvant hormone therapy boosts intra-prostatic infiltration of both cytotoxic-effector and regulatory T lymphocytes in prostate cancer patients. 47
Lack of IL-12Rbeta2 signalling predisposes to spontaneous autoimmunity and malignancy. 44
Involvement of Several Immunoregulatory Cell Subsets in Human Cardiac Allograft Rejection. 43
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines 40
null 39
null 36
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival 29
null 28
Oxidative Stress, Mutations and Chromosomal Aberrations Induced by In Vitro and In Vivo Exposure to Furan 28
null 25
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges 25
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways 24
The multifaceted role of the stroma in the healthy prostate and prostate cancer 18
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 14
Oxidative Stress and Age-Related Tumors 12
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality 12
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs 10
Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing 8
Nanomedicine for cancer patient-centered care 8
State of the art CRISPR-based strategies for cancer diagnostics and treatment 2
Totale 4.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 0 0 0 0 0 0 0 0 0 50 2
2020/2021289 43 0 48 6 35 58 9 3 14 38 6 29
2021/2022262 16 2 15 48 22 15 6 20 15 12 27 64
2022/2023837 57 95 48 93 83 164 38 62 116 35 26 20
2023/2024301 27 18 27 5 15 70 99 11 1 4 2 22
2024/2025880 63 141 162 81 28 38 40 69 141 71 46 0
Totale 4.125